Article
Doxorubicin-Induced p53 Interferes with Mitophagy in Cardiac Fibroblasts
2019-06-17
Abstract excerpt
Doxorubicin is a mainstay in pediatric chemotherapy treatment because of its efficacy treating leukemia and lymphoma. Unfortunately, every childhood cancer survivor will develop a chronic health problem, one of the most serious being cardiac disease. How doxorubicin damages the heart in such a way that disease progression occurs over multiple decades is still not understood. The dose of doxorubicin selected does n...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 19f08e2b-e226-5a47-97b6-53e1712d8362
- DOI
- 10.1101/674309
